SCHEMBL4052504

SCHEMBL4052504

OC1c2cc(C=Cc3ccc4cc(F)c(F)cc4n3)ccc2C=Cc2ncccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
CASP3 P42574 1/20 0.33
ATM Q13315 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
PIM1 P11309 1/20 0.32
CYSLTR2 Q9NS75 1/20 0.32
CYSLTR1 Q9Y271 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4052503 1.00 NPC1 (0.34) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL5335884 0.88 CYSLTR2 (0.38) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL5335885 0.88 CYSLTR2 (0.38) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL4050746 0.83 KDM4E (0.33) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL4050741 0.83 KDM4E (0.33) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL4054597 0.81 CYSLTR1 (0.38) MEN1KMT2APIM1CYSLTR2CYSLTR1
SCHEMBL4054596 0.81 CYSLTR1 (0.38) MEN1KMT2APIM1CYSLTR2CYSLTR1
SCHEMBL5337055 0.80 CYSLTR2 (0.36) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL5337057 0.80 CYSLTR2 (0.36) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL5335091 0.78 CYSLTR2 (0.36) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557212-B2 Tricyclic derivatives as LTD4 antagonists LABORATORIOS ALMIRALL, S.A. (ES) 2009-07-07 US disclosed